Abstract
The commercial unavailability of chemical reference compounds for Brazilian plant species of medicinal interest represents a great barrier for the phytoterapic development, because it makes unfeasible the extracts standardization and its quality control. Phyllanthus, known popularly as quebra-pedra, it is used for years in the popular medicine and its potentiality as phytotherapic has b…